PBRM1 and kidney cancer: PBRM1, another component of the SWI/SNF complex, is found mutated in 41% of renal clear cell carcinomas, and sunitinib, a common clinical kidney cancer treatment, has no significant effect on PBRM1‐mutated renal clear cell carcinomas, but it is sensitive to anti‐VEGF drugs.71, 72